175 related articles for article (PubMed ID: 15654274)
1. Hypercalcemia and childhood cancer: a 7-year experience.
Kerdudo C; Aerts I; Fattet S; Chevret L; Pacquement H; Doz F; Michon J; Garabedian M; Orbach D
J Pediatr Hematol Oncol; 2005 Jan; 27(1):23-7. PubMed ID: 15654274
[TBL] [Abstract][Full Text] [Related]
2. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Young G; Shende A
Med Pediatr Oncol; 1998 Feb; 30(2):117-21. PubMed ID: 9403021
[TBL] [Abstract][Full Text] [Related]
3. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.
Nussbaum SR; Younger J; Vandepol CJ; Gagel RF; Zubler MA; Chapman R; Henderson IC; Mallette LE
Am J Med; 1993 Sep; 95(3):297-304. PubMed ID: 8368227
[TBL] [Abstract][Full Text] [Related]
4. [Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
8. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
9. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone.
Gucalp R; Theriault R; Gill I; Madajewicz S; Chapman R; Navari R; Ahmann F; Zelenakas K; Heffernan M; Knight RD
Arch Intern Med; 1994 Sep; 154(17):1935-44. PubMed ID: 8074597
[TBL] [Abstract][Full Text] [Related]
11. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
[TBL] [Abstract][Full Text] [Related]
13. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
Sangun O; Dundar BN; Erdogan E
J Pediatr Endocrinol Metab; 2011; 24(1-2):69-70. PubMed ID: 21528818
[TBL] [Abstract][Full Text] [Related]
14. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
[TBL] [Abstract][Full Text] [Related]
15. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
16. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
Pecherstorfer M; Steinhauer EU; Rizzoli R; Wetterwald M; Bergström B
Support Care Cancer; 2003 Aug; 11(8):539-47. PubMed ID: 12783289
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
Alos N; Eugène D; Fillion M; Powell J; Kokta V; Chabot G
Horm Res; 2006; 65(6):289-94. PubMed ID: 16612105
[TBL] [Abstract][Full Text] [Related]
19. Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
Nikolic-Tomasević Z; Jelic S; Popov I; Radosavljević D; Mitrović L
Oncology; 2001; 60(2):123-6. PubMed ID: 11244326
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates for treatment of childhood hypercalcemia.
Lteif AN; Zimmerman D
Pediatrics; 1998 Oct; 102(4 Pt 1):990-3. PubMed ID: 9755274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
